SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/03/22 UnitedHealth Group Inc. 8-K:7,9 10/03/22 11:197K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 28K 2: EX-99.1 Miscellaneous Exhibit HTML 7K 6: R1 Cover HTML 47K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- tm2226855d2_8k_htm XML 15K 8: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- unh-20221003_lab XML 96K 5: EX-101.PRE XBRL Presentations -- unh-20221003_pre XML 64K 3: EX-101.SCH XBRL Schema -- unh-20221003 XSD 12K 10: JSON XBRL Instance as JSON Data -- MetaLinks 25± 32K 11: ZIP XBRL Zipped Folder -- 0001104659-22-104936-xbrl Zip 16K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Current Report
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): i October 3, 2022
i UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
i Delaware | i 1-10864 | i 41-1321939 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
i UnitedHealth Group Center, i 9900 Bren Road East, i Minnetonka, i Minnesota | i 55343 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: ( i 952) i 936-1300
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) |
Name of each exchange on which registered | ||
i Common Stock, $.01 par value | i UNH | i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
i ¨ | Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
C:
Item 7.01. | Regulation FD Disclosure. |
On October 3, 2022, Optum issued a press release announcing the completion of its combination with Change Healthcare Inc. A copy of Optum’s press release is being furnished as Exhibit 99.1 to this Form 8-K.
The information set forth in this Item 7.01, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any UnitedHealth Group filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. | Financial Statements and Exhibits. |
Exhibit | Description |
99.1 | Press Release dated October 3, 2022 |
104 | Cover Page Interactive Data File (formatted as Inline XBRL) |
C:
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 3, 2022
UNITEDHEALTH GROUP INCORPORATED | ||
By: | ||
Faraz A. Choudhry | ||
Assistant Corporate Secretary |
C:
C:
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 10/3/22 | None on these Dates | ||
List all Filings |